Group 1 - Barclays has cut the price target for Blackstone Inc. (BX) from $164 to $126 while maintaining an Equal Weight rating, citing early uncertainty regarding the impact of AI on portfolio companies and lowering earnings estimates for business development companies due to reduced flow assumptions [1] - Blackstone Life Sciences (BXLS) announced a funding agreement to advance the clinical development of bleximenib, an investigational oral menin inhibitor for acute myeloid leukemia (AML), which is noted as a challenging ailment to treat with the lowest survival rates among leukemia types [2] - Johnson & Johnson and funds managed by BXLS will co-finance ongoing and future clinical trials of bleximenib in AML, marking the first co-funding agreement between BXLS and Johnson & Johnson [3] Group 2 - Blackstone Inc. operates through segments including Real Estate, Private Equity, Credit and Insurance, and Hedge Fund Solutions, providing investment and fund management services [3]

Core Viewpoint - The article discusses the best stocks with significant upside potential as identified by Reddit, emphasizing the importance of AI advancements and market sentiment in investment decisions [1][4]. Market Trends - Tom Lee from Fundstrat highlighted that AI is improving rapidly, with substantial spending, but the economic impact remains uncertain, particularly for the US and China, which are the main beneficiaries [1]. - Lee noted that recent market pessimism may be overblown, suggesting that the S&P 500 could benefit from AI developments [1]. Stock Analysis - **CrowdStrike Holdings, Inc. (NASDAQ:CRWD)**: - Reported Q4 revenue of $1.31 billion, a 23% increase from $1.06 billion year-over-year [9]. - Full year revenue reached $4.81 billion, up 22% from $3.95 billion in the previous fiscal year [10]. - Achieved $5.25 billion in ending ARR, marking a record year with over $1 billion in net new ARR [11]. - **Blackstone Inc. (NYSE:BX)**: - JPMorgan reduced the price target from $158 to $122, citing increased redemption requests from 4.5% to 7.9% of net asset value [13]. - Barclays also cut its price target from $164 to $126 while maintaining an Equal Weight rating, reflecting lower flow assumptions [14]. - RBC Capital initiated coverage with an Outperform rating and a $179 price target, highlighting Blackstone's first-mover advantage in private wealth management [15].

Group 1: Company Overview - Blackstone Inc. (NYSE:BX) is recognized as one of the most profitable stocks on the NYSE to buy currently [1] - The company provides investment and fund management services, with operations divided into segments: Real Estate, Private Equity, Credit and Insurance, and Hedge Fund Solutions [5] Group 2: Analyst Insights - Barclays analyst Benjamin Budish raised the price target for Blackstone Inc. to $172 from $165 while maintaining an Equal Weight rating on the stock [1] - The firm adjusted targets in the brokers, asset managers, and exchanges group as part of its 2026 outlook, expecting constructive market conditions for alternative asset managers and wealth brokers [2] Group 3: Recent Developments - On December 11, Blackstone Inc. announced a forward flow origination partnership with Harvest Commercial Capital, LLC for acquiring business loans secured by first lien mortgages on owner-occupied commercial real estate [3] - BXCI has purchased an initial portfolio of loans and established a forward flow program totaling $1 billion in loans, focusing on small business loans including SBA 504 and non-SBA conventional loans [4] - Harvest will operate as an independent entity while leveraging Blackstone's platform and capital base, maintaining its expertise in small balance commercial loans [5]